Ya Flip I saw it the first 3 times. I understand, I get it, but it's not accomplishing anything. I also posted yesterday what Subbiah had said before intiating the trial.
Dr. Vivek Subbiah, the prime investigator and Assistant Professor in the Department of Investigational Cancer Therapeutics, Division of Cancer Medicine, commented:
“Dendritic cell cancer vaccine therapy is a new and innovative therapeutic approach in our battle against cancer. Dendritic cell technologies have been advancing, and prior studies have shown encouraging results. Patients with inoperable tumors face very bleak prognoses, and have an urgent need for new treatment options. This innovative first-in-human study of NW Bio’s DCVax-Direct for inoperable tumors in multiple types of cancer is a crucial step forward for a new approach.”
If you really want to get technical and break it down. I think there is a big difference between a company getting status reports from the trial and disseminating that information to the investing public as opposed to a lead Dr. / Hospital analyzing data and releasing it. I think this was the issue. Had the Dr released it we wouldn't be here discussing it.
News 
Market Data 
Discover 
